Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anshen Buxin Liuwei Pills for Cardiac Neurosis
NCT04932395Phase 4Unknown
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in functional cardiac symptoms comparing Anshen Buxin Liuwei Pills with Placebo (2 arms). Primary endpoint: Palpitation with Heyisheng Type Symptoms Scale in Mongolian Medicine at 8 weeks. Status: unknown.
02
Drugs
Anshen Buxin Liuwei Pill
03
Conditions
functional cardiac symptoms
Beyond the preview
Go deeper on NCT04932395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04932395.